Hawryluk P. Kent 13D/13G Filings for MBX Biosciences, Inc. Common Stock (MBX)

Hawryluk P. Kent 13D and 13G filings for MBX Biosciences, Inc. Common Stock:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-11-01
5:38 pm
Purchase
2024-09-30 13G MBX Biosciences, Inc. Common Stock
MBX
Hawryluk P. Kent 1,910,632
5.550%
1,910,632increase
(New Position)
Filing